GAMMA Investing’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7K Buy
1,738
+240
+16% +$7.62K ﹤0.01% 2298
2026
Q1
$47.2K Buy
1,498
+266
+22% +$8.38K ﹤0.01% 2219
2025
Q4
$36.3K Buy
1,232
+534
+77% +$14.8K ﹤0.01% 2281
2025
Q3
$17.6K Buy
698
+316
+83% +$7.7K ﹤0.01% 2583
2025
Q2
$9.17K Sell
382
-20
-5% -$464 ﹤0.01% 2851
2025
Q1
$9.21K Sell
402
-438
-52% -$10.6K ﹤0.01% 2785
2024
Q4
$21.3K Buy
840
+70
+9% +$1.77K ﹤0.01% 2235
2024
Q3
$19.2K Buy
770
+267
+53% +$7.91K ﹤0.01% 2132
2024
Q2
$14.9K Sell
503
-62
-11% -$1.72K ﹤0.01% 2039
2024
Q1
$17K Buy
565
+460
+438% +$12.8K ﹤0.01% 1753
2023
Q4
$2.73K Buy
+105
New +$3.08K ﹤0.01% 2479

Other funds holding RTO

GAMMA Investing's RTO Position: Q2 2026 in Review

GAMMA Investing increased its Rentokil (RTO) stake by 16% in Q2 2026, buying an estimated $7.62K and bringing the position to 1,738 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

GAMMA Investing first reported a position in RTO in Q4 2023 and has held it in 11 quarters since. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • GAMMA Investing held 1,738 shares of Rentokil worth $49.7K as of Q2 2026.
  • GAMMA Investing bought 240 Rentokil shares in Q2 2026, an estimated $7.62K.
  • Rentokil made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2298 holding.
  • GAMMA Investing first reported a position in Rentokil in Q4 2023 and has held it in 11 quarters since.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.